CSS
TYRA icon

Cubist Systematic Strategies’s Tyra Biosciences TYRA Stock Holding History

Cubist Systematic Strategies’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$550K Sell
39,310
-82,726
-68% -$943K ﹤0.01% 2235
2025
Q2 		$1.17M Buy
122,036
+30,192
+33% +$287K 0.01% 1861
2025
Q1 		$854K Sell
91,844
-17,904
-16% -$232K 0.01% 1899
2024
Q4 		$1.53M Buy
+109,748
New +$1.99M 0.01% 1541

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Cubist Systematic Strategies's TYRA Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its Tyra Biosciences (TYRA) stake by 68% in Q3 2025, selling an estimated $943K and leaving 39,310 shares worth $550K. The position accounts for ﹤0.01% of the portfolio, ranked #2235.

Cubist Systematic Strategies first reported a position in TYRA in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.53M in Q4 2024. 116 funds tracked by Wall St. Rank hold TYRA as of Q3 2025.

  • Cubist Systematic Strategies held 39,310 shares of Tyra Biosciences worth $550K as of Q3 2025.
  • Cubist Systematic Strategies sold 82,726 Tyra Biosciences shares in Q3 2025, an estimated $943K.
  • Tyra Biosciences made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2235 holding.
  • Cubist Systematic Strategies first reported a position in Tyra Biosciences in Q4 2024 and has held it in 4 quarters since.
  • Cubist Systematic Strategies's Tyra Biosciences position peaked at $1.53M in Q4 2024.
  • 116 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.